| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Morad SA et al. | A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells. | 2013 | Mol. Pharmacol. | pmid:23208958 |
| Chashoo G et al. | Potentiation of the antitumor effect of 11-keto-β-boswellic acid by its 3-α-hexanoyloxy derivative. | 2011 | Eur. J. Pharmacol. | pmid:21821018 |
| Chashoo G et al. | A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition. | 2011 | Chem. Biol. Interact. | pmid:21056033 |
| Tausch L et al. | Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense. | 2009 | J. Immunol. | pmid:19648270 |
| Pang X et al. | Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. | 2009 | Cancer Res. | pmid:19567671 |
| Krüger P et al. | Metabolism of boswellic acids in vitro and in vivo. | 2008 | Drug Metab. Dispos. | pmid:18356270 |
| pmid: | ||||
| pmid:23013292 | ||||
| pmid:21409679 | ||||
| pmid:29513961 | ||||
| pmid:28627258 | ||||
| pmid:28403501 | ||||
| pmid:27997878 | ||||
| pmid:27329304 | ||||
| pmid:26454138 | ||||
| pmid:25951322 | ||||
| pmid:25618017 | ||||
| pmid:25452227 | ||||
| pmid:24806456 | ||||
| pmid:24463070 | ||||
| pmid:24168329 | ||||
| pmid:23962801 | ||||
| pmid:23797329 | ||||
| pmid:23771412 | ||||
| pmid:22167571 | ||||
| pmid:21779845 | ||||
| pmid:21751262 | ||||
| pmid:21334793 | ||||
| pmid:20538386 | ||||
| pmid:19010411 | ||||
| pmid:17101304 | ||||
| pmid:12008153 | ||||
| pmid:11793815 | ||||
| pmid:26117531 |
11-keto-beta-boswellic acid
11-keto-beta-boswellic acid is a lipid of Prenol Lipids (PR) class.
Cross Reference
